Neuroendocrine Prostate Cancer

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB13017Rovalpituzumab Tesirine1 / 2Terminated1
DB05220Alisertib2Completed1